Because uPAR promotes tumor progression and invasion, various strategies for blocking uPA-uPAR interaction or uPAR-mediated downstream signaling are being developed to inhibit tumor growth and metastasis [12-15]. The gene discussed is PLAU; the disease is neoplasm.